Prioritising cancer therapeutic targets via CRISPR-Cas9 screens and multi-omics data integration
Prioritising cancer therapeutic targets via CRISPR-Cas9 screens and multi-omics data integration
Alle ore 16.00 il dott Francesco Iorio (nella foto -Photo courtesy: Wellcome Sanger